Examples of Therapeutics Field in a sentence
Subject to the rights of the Primary Sublicensors and their respective owners under Section 10.4, Cellscript, mRNA RiboTherapeutics and Company agree that, from the Effective Date until [***], mRNA RiboTherapeutics and Cellscript will not grant and will ensure that other Primary Sublicensors will not grant Human In Vivo Therapeutics Field Sublicenses[***].
The Parties shall establish a Research Committee comprised of four (4) members for the Agrochemical Field and the Human Therapeutics Field within thirty (30) days after the Effective Date, with two (2) representatives appointed by each Party for each such Research Committee, unless otherwise agreed by the Parties.
The Mayors of the outer atolls appoint the Cultural Resource Officers who may report back to the HPO should there be problems with visitors and diving.Additionally, the HPO issues Dive Tour Operator Affidavits which place the tour operator as monitor of the responsible party for implementation of the legislation.
The selection of the party with whom Dyax ultimately chooses to enter into such an outlicense in the Other Therapeutics Field shall be Dyax's.
Licensee will meet the following Development Milestones with respect to a Licensed Product in the Therapeutics Field.
The response shall include a grant of exclusive license rights from Dyax to Bracco to such Collaboration Lead or Bracco Lead, as the case may be, to research, develop, make, have made, use, import and have sold Licensed Products in the Other Therapeutics Field for the milestones and royalties payments set forth in Section 6.6, hereof or designate the agreement that precludes the granting of the license to Bracco.
A non-exclusive, world-wide, non-transferable, fully paid, royalty free license, without the right to sublicense, to make, have made, use, import, export, lease, sell, offer to sell or otherwise transfer Licensed Products, Licensed Processes, and Licensed Technology and Know-How in the Therapeutics Field, subject to the rights of Agilent set forth in Sections 2(a)(5) and 3.
Any license that has been granted to Bracco to the exclusive use of a Collaboration Lead, Bracco Lead or Dyax Lead in the Bracco Therapeutics Field pursuant to Section 4.2 shall also remain exclusive, subject to the requirements of Section 5.4 and any license that has been granted to Bracco to the exclusive use of a Collaboration Lead or a Bracco Lead in the Other Therapeutics Field pursuant to Section 4.3 shall remain exclusive, subject to the requirements of Section 5.4.
With respect to the Bracco Therapeutics Field, Dyax may only withhold approval if Dyax has a program in the Other Therapeutics Field, or if any third party rights arising from an Existing Agreement limit the use of the Target in the Bracco Therapeutic Field.
For so long as the licenses to the Collaboration Lead or Bracco Lead granted to Bracco in Section 4.1 in the Diagnostic Imaging Field remain exclusive, Bracco shall have an option to obtain a license from Dyax to the exclusive use of such Collaboration Lead or Bracco Lead in the Other Therapeutics Field, unless Dyax is precluded from granting the license by an agreement existing or in negotiation with a third party at the time that Bracco seeks to exercise the option.